AIM-listed fund Elephant Capital has acquired a 28.6% stake in ClinTec Luxembourg, a global clinical research organization. ClinTec, headquartered in Glasgow, provides clinical research personnel and project management services to pharmaceutical and medical device companies. Elephant Capital’s investment paves the way for ClinTec’s expansion in India and other emerging markets. David Roberts, a corporate partner and head of the India practice at Olswang, advised Elephant Capital on the deal. “We have been admirers of Elephant Capital for some time now and it is great to help them to complete their investment in ClinTec,” he said.
You must be a
subscribersubscribersubscribersubscriber
to read this content, please
subscribesubscribesubscribesubscribe
today.
For group subscribers, please click here to access.
Interested in group subscription? Please contact us.
你需要登录去解锁本文内容。欢迎注册账号。如果想阅读月刊所有文章，欢迎成为我们的订阅会员成为我们的订阅会员。
